Skip to Main Content

Paper Details

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
J Natl Cancer Inst
19
2017
3p21, KIF15 gene, LMO1 neuroblastoma risk locus, MYCN, MYCN-Amplified Neuroblastoma, MYCN-amplified high-, MYCN-amplified neuroblastoma, MYCN-amplified tumors, high, intron 16, neuroblastoma, patients, rs80059929, single nucleotide polymorphism
Author NameAffiliation
Andrew D Skoland Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Andrew D Skoland Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Zalman Vaksmanand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Zalman Vaksmanand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Maura Diamondand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Samuel L Volchenboumand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Samuel L Volchenboumand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Barbara E Strangerand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Barbara E Strangerand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
John M Marisand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
John M Marisand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Sharon J Diskinand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Sharon J Diskinand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
Susan L Cohnand Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, IL Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, SJD) Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research
  • 1 - 14

Datasets